Skip to main content

SEGALL BRYANT & HAMILL, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1006378 CHICAGO, IL

Position in NBIX

as of Mar 31, 2026 · filed May 22, 2026
Position Value
$7,500,485
-$508,655 QoQ
Shares Held
56,934
+0.8% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 50.168616292549274.ToString("F0")% Shared 0.ToString("F0")% None 49.83138370745073.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

SEGALL BRYANT & HAMILL, LLC holds $48,800,443 across 13 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (15.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
56,934 $7,500,485

All Filings in NBIX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,500,485 56,934
2025-12-31 $8,009,140 56,470
2025-09-30 $7,647,060 54,474
2025-06-30 $5,667,487 45,091
2025-03-31 $5,873,191 53,103
2024-12-31 $6,397,755 46,870
2024-09-30 $4,202,303 36,472
2024-06-30 $5,091,587 36,984
2024-03-31 $2,768,881 20,076